series-c
Stage
2
Investors
About
Versa Vascular develops a minimally invasive medical device and delivery system for treating severe tricuspid regurgitation through transcatheter tricuspid valve repair, aiming to improve patient outcomes without surgery.
Explore Versa Vascular's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.